Meaningful Moments
Impact Report & Audited Accounts 2025/26
northlondonhospice.org
Contents
| Contents | |
|---|---|
| Message from Chair and Chief Executive | 4 |
| Our Commitment | 6 |
| Moments of Care | 8 |
| In The Community | 10 |
| A Gesture That Made a Difference | 12 |
| The Space to be Heard | 14 |
| Strengthening Wellbeing | 16 |
| Enabling Meaningful Living | 18 |
| Hearts and Minds | 20 |
| The Gift of Time | 22 |
| Stories Behind the Sales | 24 |
| The Power of Giving | 26 |
| Building Connection | 28 |
| Trusted Partners in Care | 30 |
| Trustees’ Annual Report | 32 |
| Complaints and Concerns | 40 |
| Financial Review of the Year | 41 |
| Our Trustees | 44 |
| Our Executive Team | 45 |
| Independent Auditors Report | 46 |
| Statement of Financial Activities | 49 |
The Board of Trustees of the North London Hospice (‘The Hospice’) presents its Impact Report & Audited Accounts for the year ended 31 March 2026 in accordance with the provisions of the Companies Act 2006 and the CharitiesAct 2011. The audited accounts for that year are also presented and comply with the Companies Act 2006, the hospice’s governing document and the Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019).
2
3
Message from Chair Contents and Chief Executive
This has been a year of both challenge and determination. We have faced real financial pressures, growing demand and the complexity of delivering care in an increasingly constrained system. Despite this, what stands out most is the organisation’s ability to hold its purpose; continuing to provide compassionate, highquality care to patients and families when they need it most.
In addition – and because of this commitment – work has begun on one of the most ambitious projects undertaken since our hospice was built in the early 1990s. In those three decades, while our models of care have adapted and advanced, our facilities and structures have not. Now, our building is holding us back. After extensive consultation and research, including exploring several different options, we have concluded that a complete redevelopment of the Inpatient Unit is the best solution in order to meet the evolving needs of our patients.
Simon Morris MBE Chair, Board of Trustees
North London Hospice is proud to be continuing to provide specialist care and inpatient services during this period, temporarily relocating to the Jade Ward at Edgware Hospital. Our hospice was built by our community, for our community. The project, Building For Tomorrow, is being funded through a mixture of major donors and trusts as well as some government funding. The hospice will be launching a public appeal in autumn, asking the community to come together to all support the charity, just like they did more than 40 years ago.
In another major area of our work, we were delighted to see our retail estate grow to 21 shops across North London this year, a significant milestone in the continued development of retail as a vital part of how we fund our services. This ambitious expansion reflects the progress we have made over the past two years and the growing role our shops play in supporting the hospice’s long-term sustainability. Further opportunities also remain under active consideration as part of our longer-term plans.
Declan Carroll Chief Executive
Alongside this, we have taken important steps to strengthen our foundations through enhanced governance and a sharper focus on quality and safety. This combination of resilience and renewal is a real source of confidence. We have also taken the opportunity to reflect honestly on areas where we could be even stronger, particularly within parts of our clinical services. By addressing these opportunities constructively, we are building a more supportive and inclusive environment. Even in a demanding landscape, the professionalism, dedication and compassion of our staff and volunteers continue to stand out. Teams have supported one another, adapted with agility and consistently delivered high standards of care in every interaction.
Hospice care remained in the national spotlight this year, as debate around the Assisted Dying Bill brought renewed attention to the vital role that hospices play in supporting people at the end of life. The discussion highlighted not only the importance of ensuring access to highquality, compassionate care, but also the need for hospice services to be sustainably and fairly funded. This aligns with the ongoing challenges facing our sector, where the cost of delivering care continues to rise while income has not kept pace.
We are happy to be working with the new West & North London Integrated Care Board (ICB) together with other local partner hospices to shape the future of hospice care for us all. Hospices like ours provide essential services that complement and extend those available through the NHS, supporting patients and families when they need us most. Sustainable, long-term funding remains critical if we are to continue delivering these specialist services. We are pleased to have a positive and constructive dialogue with our ICB, and whilst their financial contribution is greatly valued, it underlines the significant reliance that our hospice continues to place on charitable funding and community support. We will continue to work closely with our ICB, Hospice UK and other partners to advocate for a funding model that more fully reflects the value and impact of hospice care, while safeguarding the outstanding care our patients and families rely upon.
Of course, as is the nature of hospice care, much of our impact cannot be captured in numbers. It is in the quiet moments; being with a family at the end of life, supporting difficult
conversations, or helping someone feel safe and heard during an uncertain time. We continue to provide not just clinical care, but emotional and practical support that allows people to live as fully as possible until they die. For many families, that support shapes their experience of loss and bereavement in ways that stay with them long after our formal involvement ends.
The coming year is about building on the progress we have made across the organisation. That includes strengthening our financial sustainability, continuing to embed cultural improvements and ensuring that the quality and safety of our care remains at the highest standard. At the same time, we will continue to invest in our people and in the future of our services, including our facilities and digital capability, so that we can meet growing demand and deliver care in the right way for our communities. That combination of values and rigour is what will sustain us.
None of this would be possible without the loyalty and generosity of our supporters. Every donation, partnership and contribution helps us be there for patients and families at the most important time. In a year of real challenge, where funding has not kept pace with need, their continued commitment has allowed us not only to fortify our services but to keep improving them.
We can’t put a value on what our services mean to all the patients, families and friends that we have cared for and supported over the years and will continue to support for years to come, but we can talk with pride, as we hope you all do, about how important our work is at North London Hospice. We would like to thank all our staff, trustees, donors, volunteers and supporters for everything they do to continue to help us achieve our aims. Despite ongoing significant pressures, they have risen to the many varied challenges we have experienced. We hope you find this report helpful and informative.
Simon Morris MBE Declan Carroll Chair, Board of Trustees Chief Executive
5
Contents Our Commitment
Our Vision
The best of life, at the end of life, for everyone
Our Purpose
North London Hospice - working together to provide palliative care and support, when and where you need us most
Our Values
C Collaborative and learning O Open and honest R Respectful and empowering E Equal and inclusive
6
NLH 7
Moments of Care Contents
Inpatient Unit
285 admissions
91% occupancy
91% of patients achieving their preferred place of death
Meaningful Moment
A patient on our Inpatient Unit longed to stroke a cat, so we arranged for Minnie, a calm and affectionate British Blue, to visit. Seeing him cuddle Minnie, recall memories of his own pets and share that joy with his family created a deeply emotional and unforgettable moment of comfort, connection and compassion.
Green Pledge
Our Building For Tomorrow campaign will focus on the major redevelopment of our Inpatient Unit to create a state-of-the-art, sustainable facility for patients and their families that will continue to meet their complex care needs now and into the future.
8
9
In The Community
Community Palliative Care Services 3,078 referrals
90% of patients achieving their preferred place of death
5,834 total number of calls received through our overnight specialist Community and Palliative Advice Team (5pm-8am)
Meaningful Moment
Our new Rapid Response Service was established this year, delivering specialist, same-day care when time is critical. Now the sole focus of a newly formulated nurse-led team, patients with the most acute need are seen in under two hours, to help alleviate physical suffering and support emotional wellbeing swiftly.
We are immensely grateful to The Ernest Hecht Charitable Foundation for their generous donation of £240,000, which will continue to play a vital role in sustaining the Rapid Response service through the coming year.
Green Pledge
Over the coming year we will be specifically monitoring demand for our care alongside the resources required to provide it, including travel, energy use, medicines, equipment and waste to measure our environmental impact transparently. This will help us to reduce our carbon footprint and resource intensity per patient wherever possible, seeking low-carbon, efficient and sustainable ways of working that do not compromise care.
111
A Gesture That Made a Difference
It was the most intense and emotional time of our lives, but we felt safe at the hospice
Alison couldn’t tell you if she was frightened or in pain. She didn’t have the words
In extraordinary circumstances that held both comfort and sorrow, father and daughter shared neighbouring rooms on our Inpatient Unit recently. Side-by-side they could feel each other’s nearness, a quiet tether of love and familiarity amid the weight of illness and loss.
Eamonn was a gardener by profession and a gentle and practical man who loved the outdoors. A bitter blow, his liver cancer diagnosis led to a year of gruelling treatment supported by the hospice’s community team. It was just days after celebrating his 50th wedding anniversary with his wife Lesley in September 2025 that he came to the unit. No one could’ve imagined that his daughter Alison would also come into our care.
Alison was just 44 when she was diagnosed with colon cancer. Despite living with complex learning disabilities, she had otherwise always been well. It was the loss of her vivacious personality, penchant for cuddles and love of walking that prompted the many tests which revealed her illness and that no treatment was available.
It was the hospice team who suggested moving father and daughter into neighbouring rooms, so that Lesley and Laura - Alison’s sister and Eamonn’s daughter - could move easily between them, never feeling torn, able to be present for them both.
“That meant everything to us,” Lesley shared.
To know they were side by side and that they could feel each other there gave me such comfort. I could sit with Eamonn and then walk just a few steps to Alison. I didn’t have to choose. As a wife and a mum, that’s an impossible position to be in, but you made it possible.
And for the first time in a medical situation with her daughter, Lesley felt heard.
“Alison couldn’t tell you if she was frightened or in pain. She didn’t have the words,” Lesley added.
“My biggest fear was that she would be suffering and not be able to say. But they watched her so closely and learned her little sounds and expressions. One of the healthcare assistants even brought her a dolly and sang to her. For the first time in her life, I felt that professionals truly listened to me as her mum. That meant more than I can ever explain.”
Both Eamonn and Alison died peacefully towards the end of 2025.
To have my dad and my sister dying of cancer at the same time felt like the worst possible luck,” Laura reflected.
But what stands out isn’t just the sadness. It’s how every single person, from the doctors to the housekeeping staff, treated them and us. It never felt like just a job. They managed to be chatty, warm and sensitive and came together in our family’s best interests.
Months later, Lesley and Laura returned to North London Hospice armed with 21 handwritten thank you cards and said they could have written more.
“It was the most intense and emotional time of our lives, but we felt safe at the hospice,” Lesley acknowledged.
“Everyone took us under their wing. In the worst moment of our lives, that was a gift I will always be thankful for.”
12 NLH IMPACT REPORT
13
The Space to be Heard Contents
Patient and Family Support Services Patient and Family Support Services
1,300 number of people assisted by our support services (social work, bereavement, spiritual care)
Meaningful Moment
We brought our commitment to improving cultural awareness to life by creating a powerful new video series exploring death and dying through different faith and belief perspectives. Travelling to film faith leaders in the places where they worship and serve, we captured voices that will enrich our organisation and strengthen our connection with the communities we care for. Through this project, we deepened our understanding of the humanity, compassion and wisdom that spirituality brings at the end of life.
Green
Moments
We minimised our carbon footprint by
reducing unnecessary travel, prioritising remote communication and ensuring that in-person visits are purposeful and efficiently planned. We have adopted a digital-first, low-waste approach, cutting paper use, reducing postage and fuel consumption, recycling responsibly and streamlining processes to conserve resources while continuing to deliver high-quality support.
14
15
Strengthening Contents Wellbeing
Outpatient and Wellbeing
964 engagements with Outpatient and Wellbeing services
Meaningful Moment
Our first Living Well Centre opened its doors in Wood Green, providing accessible, community-based support for health, wellbeing and connection.
Green Pledge
To deliver a sustainable programme that places climate responsibility, community resilience and social value at its core. Our neighbourhood-based model will minimise carbon impact, champion low-resource delivery and work in partnership with local grassroots organisations to maximise shared assets and prevent duplication and advance both community health and the wider green agenda.
16 NLH IMPACT REPORT
117
Enabling Meaningful Contents Living
Before Mimi’s diagnosis, the 44-year-old from Colindale had been training as a reflexologist, embracing a more intentional way of living and building a lifestyle rooted in holistic wellbeing. But in May 2025, this new path was abruptly interrupted when doctors delivered the devastating news that Mimi had metastatic breast cancer.
Riddled with unbearable pain and struggling to breathe, it was during a hospital admission that she was encouraged to reach out to the community team at North London Hospice; an introduction that would come to reshape her experience of care in ways both practical and deeply personal.
“I remember the nurse coming to see me at home and she asked me how I was. I just told her how I really felt that I'd not told anyone before and cried,” Mimi recalled.
“It wasn’t planned; it just happened. But she didn’t interrupt me or try to make it better straight away. She just sat and listened. That meant so much, because in that moment I didn’t need solutions, I just needed someone to hear me. It made me feel safe, like I wasn’t going through it on my own.”
From that point on, it was often the small, practical interventions that had the greatest impact on Mimi’s daily life. This included applying for relevant benefits on her behalf, with the thought of completing a form proving overwhelming.
“It sounds like such a simple thing but the special comfort chair that the team arranged for me changed everything,” Mimi admitted.
“Before, even sitting down was uncomfortable and I was always shifting, trying to find a position that didn’t hurt. Then suddenly I had somewhere I could properly rest and a way to lift myself back out of it. That’s something you really appreciate when you’ve been without it.”
And as her hip pain worsened, the introduction of a walker became another turning point.
“By providing me with this equipment and helping me find the strength to use it, I had my independence gifted back to me,” Mimi shared.
“I could walk to the local café with a friend. So simple but so liberating. I didn’t feel as stuck. It helped me feel like my old self again.”
Alongside this, she has received complementary therapies, nursing and doctor-led home help and social worker support for both Mimi and her mum, who has become her carer as Mimi was forced to move back home.
“Everyone is full of patience and reassurance, which is a huge comfort,” Mimi reflected.
“I know some people find the idea of hospice care frightening, but the way I see it, facing a situation like this alone is so much scarier and I am amazed and extremely grateful that such a caring service exists.”
Mimi continues to receive treatment and some days are harder than others, but she is keen to acknowledge that she doesn’t feel alone.
“My family and friends are so kind and supportive and I am learning to ask for help and allow people to look after me,” she concludes.
“My faith offers me comfort and I draw on both my Buddhist and Catholic backgrounds to help me feel calm, helped and hopeful. But that quiet consistent care from the community team has made a profound difference too. I am less scared, less lonely and less overwhelmed because of North London Hospice. This is humanity at its finest really and I am immensely grateful to have the hospice in my corner.”
18
19
Hearts and Minds Contents
Learning and Development
131 training sessions for staff
1,104 courses delivered to external learners
Meaningful Moment
We welcomed hospice nurses from Malta to share best practice and strengthen international collaboration in end-of-life care.
Green Moments
We maintained paperless teaching with digital handouts and an online prospectus, while at events we prioritised sustainable choices, avoiding disposable plastics. Social sustainability remains central, as our L&D framework, apprenticeships and leadership programmes develop a resilient, highly skilled workforce and ensure specialist knowledge is preserved for the future. We also focused on economic sustainability, carefully managing our budget through quality-assured external training, negotiated discounts, reciprocal arrangements and active promotion of educational grants to maximise learning opportunities.
20
21
The Gift of Time Contents
Volunteering 611 volunteers
Meaningful Moment
Local MP Bambos Charalambous hosted our volunteers at a special gathering to mark Volunteers’ Week. The event was held in the Jubilee Room of the House of Commons and was an opportunity for volunteers to meet each other, and more importantly, for the hospice to say thank you for all that they do.
Green Pledge
Toward the end of 2025 we initiated a major project to combine several people systems into one unified platform. This coming year, our volunteering network will be brought into this streamlined system, creating a more connected, efficient and sustainable way of working. By simplifying processes, reducing paper and administrative waste and improving data accuracy, we are embedding sustainability into the core of how we operate.
----- Start of picture text -----
23
----- End of picture text -----
22 NLH IMPACT REPORT
Stories Behind the Contents Sales
Retail
46,186 number of Gift Aid registered donors
321 number of retail volunteers
Meaningful Moment
We opened three new shops across Islington and Camden, bringing our network to 21 locations and increasing the support they provide for our hospice services.
Green Moments
In partnership with sustainable denim hub LaundRe, our shops are selling refinished unsold, vintage and pre-worn denim to extend garment life and support a more circular UK fashion economy.
24
25
The Power of Giving Contents
Fundraising
7,337 people and organisations supported us by giving us a gift
39 notifications received of a gift left to us in their will
Meaningful Moment
Seeing families come together at Forever in our Hearts – Forever Feathers was incredibly moving. The event provided an outlet to honour loved ones, strengthened the hospice community and raised vital funds, highlighting the compassion and support at the heart of everything we do.
Green
Moments
We focused on promoting gifts in wills, a vital source of income, to build a pipeline of future legacy support. Looking ahead, we will also grow the number of regular givers, providing a stable and sustainable income to help more supporters make a lasting impact.
26
27
Building Connection Contents
Communications
followers across our social media 14,845 channels
14,447 people receive our newsletters
- 1,725 average monthly website visitors
Meaningful Moment
Our new website launched in January 2026, improving access to information, resources and support for patients and families. It follows the standards set out in the Web Content Accessibility Guidelines (WCAG) 2.1. to make it as accessible as possible to everyone regardless of ability.
Green
Moments
With 23 newly installed digiboards in place across our retail and patient care sites, we’re cutting paper waste, reducing carbon emissions, saving energy and minimising the environmental impact of printed materials.
28
29
Trusted Partners Contents in Care
We offer our heartfelt thanks to the following supporters who have all made donations of £5,000 or more to North London Hospice in the last year.
Benecare Foundation
Breast Cancer Sisters City Bridge Foundation Daniela and Sean Fung David & Caroline Foord Dr French Foundation Dr Samantha Edward Ernest Hecht Charitable Foundation Finchley Golf Club H & M Charitable Trust H&T Clients Charitable Trust Hampstead Garden Suburb Fellowship Isabel Gibson Jesus Hospital in Chipping Barnet Kevin Jones Lee Family Lynette and Robert Craig Neophytou Family and Friends No Surrender Cancer Trust
Paul A Harris Penny Gluckstein MBE Proms at St Jude’s Rajeshri Khatri's family and friends Ruth and Nigel Wildish Saloman Foundation Sisters of the Holy Cross The Albert Hunt Trust The Gillespie Family The Grace Trust The Happy Charitable Trust The Koumouris Family The Malachim Foundation The Milton Damerel Trust The Rayne Trust The Thompson Family Charitable Trust The WFH Foundation Tobin Family Wood Green Crown Court
North London Hospice also acknowledges all other valued supporters who wish to remain anonymous.
30
31
Trustees’ Annual Report for the year ending 31 March 2026
How We Are Governed
North London Hospice is a company limited by guarantee – registered number 1654807 and a registered charity in England and Wales (charity number 285300). Our constitution is our Articles of Association, which were first adopted on 29 July 1982 and amended on 13 January 2022. The hospice has a wholly owned subsidiary ‘North London Hospice’ (Trading) Limited (Company Number 2268094) – the subsidiary company did not trade in the year ending 31 March 2026.
Objectives and Principal Activities:
The hospice’s objectives are:
-
To relieve sickness and suffering and, in particular but without prejudice to the generality of the foregoing, by the establishment and maintenance of a hospice in North London for persons suffering from chronic or terminal diseases.
-
To relieve the suffering of the families and friends and in particular, but without prejudice to the generality of the foregoing, by the provision of practical, bereavement and other emotional support and programmes for education and advice.
Structure, Governance and Management
The trustees have taken account of the Charity Commission’s general guidance on public benefit when reviewing our aims, objectives and planning.
Our Trustees
Our charity is governed by the Board of Trustees who are legally responsible for directing our affairs. The board determines our long-term strategy and approves our annual strategic priorities and budget. Specific responsibilities are delegated to a number of committees, which report back to the board on a regular basis. The board delegates day-to-day management of the charity to the Chief Executive and the Executive Team.
Board Committees
Board Development and Remuneration Committee
Responsible for board governance arrangements and succession planning and recommendations for the appointment and reappointment of governance and executive positions. Oversight of the performance of the Chief Executive and recommendations to the board on the remuneration of the Chief Executive and Executive Team.
During the year under review Trustee Simon Males retired (July 2025). Simon made a valued and lasting contribution as a trustee to the work of the Board and the Executive Team, and he continues to provide advice to the Finance Committee. The organisation would like to record its sincere thanks for his commitment, insight and support.
Finance and External Audit Committee
Responsible for the strategic oversight and effective use of the charity’s financial resources and investments. To oversee associated policy, strategy and performance across all finance, investment and external audit areas.
All trustees complete an annual appraisal process with the Chair and Vice Chair, together with completion of our Fit and Proper Persons declaration and approved Code of Conduct.
Governance
Our Committee framework has been integrated positively into our governance structures. All trustees are required to disclose potential or actual conflicts of interest to the charity as part of an annual review and at the start of each meeting. The board continues to adopt the principles of good governance in the Charity Governance Code.
32
33
Clinical Governance and Assurance People and Organisational Development Committee Committee Responsible for oversight and delivery Responsible for strategic oversight of the Contents
Responsible for oversight and delivery assurance of the People, Equality, Diversity & Inclusion strategy, and Volunteering. To oversee associated policy, strategy and performance across all people (staff and volunteer) areas.
Responsible for strategic oversight of the clinical and patient services we deliver to ensure they are safe, effective, caring, responsive and well-led. Provide assurance to the board on all aspects of the quality of clinical care, clinical risk management, clinical governance systems, compliance with clinical regulatory requirements and standards of quality and safety. To oversee associated policy, strategy and performance in all clinical and patient service areas.
Retail Committee
Responsible for development and delivery of the retail strategy, exploring shop growth with return on investment and overseeing associated policy, strategy and performance across the retail potfolio.
Fundraising and Communications Committee
Please see page 44 for a full list of trustees, which also shows movements through the year under review.
Responsible for strategic oversight of the fundraising and communications delivery and services. To oversee associated policy, strategy and performance across all fundraising income areas.
Inpatient Unit Redevelopment Project Board
This sub-committee has been established to oversee the redevelopment of the inpatient unit – from concept to delivery (subject to board approval) the board will focus on establishing a brief, budget and framework for delivery of the project providing scrutiny, guidance and advice on its direction.
Statement of Trustees’ Responsibilities and Corporate Governance
The trustees are responsible for their annual report, and for the preparation of accounts for each financial year which give a true and fair view of the incoming resources and application of those resources during the year, and of the state of affairs as at the end of the financial year. In preparing these accounts, the trustees are required to:
-
the hospice is operating efficiently and effectively
-
all assets are safeguarded against unauthorised use or disposition and are properly applied
-
proper records are maintained and financial information used within the hospice, or for publication, is reliable
-
ensure that suitable accounting policies are established and applied consistently
-
the hospice complies with relevant laws and regulations.
-
make judgements and estimates which are reasonable and prudent
Reserves Policy
- state whether applicable accounting standards and statement of recommended accounting practice have been followed, subject to any material departures disclosed and explained in the accounts
The trustees recognise that the current level of reserves is slightly below the minimum requirements as per the policy, which is a reflection of the £2.7m designation of funds towards the Inpatient Unit redevelopment. The expectation is that not all of this will be required as the capital fundraising appeal proves successful.
- prepare the accounts on a going concern basis unless it is inappropriate to presume that the hospice will continue in operation
The trustees confirm that they have complied with the above requirements in preparing the accounts.
Accordingly, the existing policy is at a level that the trustees consider will be adequate. The policy is to maintain unrestricted reserves at a minimum of nine months of unrestricted operating expenditure, taking into account future forecasts.
The trustees have overall responsibility for ensuring that the hospice has appropriate systems and controls, financial and otherwise. They are also responsible for keeping proper accounting records which disclose with reasonable accuracy at any time the financial position of the hospice and enable them to ensure that the accounts comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the hospice and for their proper application as required by charity law, and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities and to provide reasonable assurance that:
Current levels of expenditure and maintaining our unrestricted general fund will ensure longterm financial stability and enable the hospice to withstand external events which may affect the level of income received. Planned investments from reserves as part of our current and future strategic priorities in 2025-27 (including additional investment in retail and a legacy buffer fund) will result in a short-term reduction of the current level of unrestricted general fund.
34
35
Investment Policy
The Memorandum and Articles of Association do not place any restrictions on the investment policy to be adopted. The trustees have invested surplus funds, whilst ensuring easy access to meet the operating costs of the hospice.
The transfer of 50% of the portfolio to Cazenove (per the 24/25 re-tendering of the investment portfolio) was completed in Q1 25/26.
At year end, the investment portfolio stood at £13.3m. The total investment return gain for the period totaled £1.5m (including investment income) and a redemption of the same amount was made during the year to increase the cash balance held for the future Inpatient Unit redevelopment.
Principal Risks and Uncertainties
The Board of Trustees has overall responsibility for risk management of North London Hospice. This includes setting the risk appetite for the charity, ensuring there are reasonable procedures in place for the prevention and detection of major risks, including fraud risk and other irregularities, and ensuring that risk procedures are reviewed when issues arise.
-
North London Hospice committee groups meet quarterly and review key risk areas, including information governance and data privacy, fraud, and bribery, safeguarding and business continuity. Risks are escalated to the board as appropriate.
-
Each directorate meets regularly to carry out reviews of risk management arrangements across the directorate and inform the escalation of the risk to the Executive Team/ Board.
-
The Executive Team, chaired by the Chief Executive, review and monitor key charity-wide strategic and operational risks at its monthly business meetings.
-
Each committee review the results of the
-
executive risk management and the operation of our risk management processes.
We have policies and procedures to identify and manage risks arising from our existing operations and strategic development, and to provide reasonable assurance against material errors or loss.
Planning and Performance
We operate a comprehensive annual planning and budgeting process. We monitor performance through use of key financial and performance indicators which compare actual results and activity against our plans and are routinely reported to each committee and to the Board of Trustees. A phased budget and regular forecasting enable the trustees and the Executive Team to link financial performance with resource and activity levels.
The Finance and External Audit Committee has delegated oversight into this area.
Internal Audit
Internal controls are subject to scrutiny by the Executive Team, Senior Management Group and our Committee cycle. We carry out a programme of cyclical and other operational reviews and audits across North London Hospice. The Executive Team review and agree the annual audit plan, scrutinises regular reports and present to each committee on progress against the audit plan, the effectiveness of controls in audited functions and reviews and recommend and action learnings from audits.
Fundraising Statement
Our approach to fundraising aims to be transparent, respectful, and compliant with the Code of Fundraising Practice. The charitable company carries out fundraising activities and voluntarily complies with the Code of Fundraising Practice. Our fundraising policies work to protect the public and vulnerable individuals. Details of the complaints received by the charity are noted on page 40 and none related to fundraising activities.
----- Start of picture text -----
37
----- End of picture text -----
36
Key Strategic Risk We reviewed our risk management strategy and process during the year under review. This included a review of our key strategic risks and our managing and reporting framework. An Contents overview of our key strategic risks and the actions we take to mitigate them is summarised in the table below. Each risk area is supported by relevant policies and procedures that are regularly reviewed and updated, and subject to compliance testing.
Risk How we mana e it g
Risk How we mana e it g
| Risk | How we manage it | |
|---|---|---|
| FUNDING & FINANCIAL STABILITY & | • Finance & External Audit Committee | |
| RESILIENCE | • Diversification of income sources | |
| Over reliance on single funding sources (e.g. grants, donations) |
• Financial planning & reserves policy • Reporting & Management |
|
| • Strengthening Donor & Funder Relationships | ||
| • Risk Management & Scenario Planning | ||
| • Digital Innovation Strategy | ||
| REGULATORY & LEGAL COMPLIANCE | • Governance & Leadership Oversight | |
| Non-compliance with Charity Commission rules, GDPR, CQC, Health & Safety, Safeguarding |
• Legal & Regulatory Compliance Framework • Internal Audits & Monitoring • Policies, Procedures & Training |
|
| • Legal Advice & Industry Best Practice | ||
| REPUTATION | • Strong Governance & Ethical Leadership | |
| Negative media attention, incidents | • Proactive Media & Communications Strategy | |
| or governance failures can damage | • Transparency & Stakeholder Engagement | |
| credibility | • Risk Management & Safeguarding | |
| • Legal & Compliance Safeguards | ||
| • Community & Corporate Partnerships | ||
| • Digital & Social Media Reputation Management |
- Trustee Board & Committee – Terms of Reference, scheme of delegation, recruitment & skills audit • Conflict of Interest Management – policy & process
GOVERNANCE & LEADERSHIP
Weak Trustee Board / committees, Executive Team, conflicts of interest, or poor strategic decision-planning & management
-
Effective Executive Team Leadership
-
Strategic Decision-Making & Risk Management
-
Legal & Regulatory Compliance
-
Board & Leadership Communication & Engagement
----- Start of picture text -----
Risk How we mana e it
g
----- End of picture text -----
| IT, DIGITAL & CYBERSECURITY | • Data Protection & GDPR Compliance | |
|---|---|---|
| Data breaches, fraud, or lack of IT/digital | • Cybersecurity Measures | |
| transformation strategies | • Fraud Prevention & IT Governance – Information | |
| Governance Steering Group | ||
| • Digital Transformation & IT Strategy | ||
| • Incident Response & Crisis Management | ||
| OPERATIONAL | • Strategic Planning & Performance Management | |
| Inefficiencies, poor resource | • Efficient Resource Allocation & Financial Management | |
| management, or inability to deliver | • Workforce & Volunteer Management | |
| services effectively | • Risk Management & Contingency Planning | |
| • Technology & Process Optimisation | ||
| • Governance & Accountability | ||
| QUALITY OF CARE | • Clinical Governance & Regulatory Compliance | |
| Failure to provide compassionate, | • Safe & Effective Care Delivery | |
| effective and safe patient centered care | • Continuous Professional Development (CPD) & Training | |
| that delivers the best clinical outcomes | • Patient Safety & Risk Management Policies & Procedures | |
| • Measuring Outcomes & Quality Improvement | ||
| • Ethical & Compassionate Care Culture | ||
| WORKFORCE & VOLUNTEER | • Recruitment & Onboarding Best Practices | |
| MANAGEMENT | • Retention & Employee Engagement | |
| Recruiting, retaining, and safeguarding | • Safeguarding & Duty of Care | |
| employees and volunteers | • Workforce Planning & Succession Management | |
| • Volunteer Management & Support | ||
| • Compliance & HR Best Practices | ||
| POLITICAL & ECONOMIC | • Financial Resilience & Diversified Funding | |
| UNCERTAINTY | • Government Policy & Compliance Monitoring | |
| Changes in government policy, inflation, | • Donor & Corporate Engagement Strategies | |
| or economic downturns impacting | • Inflation & Cost Management Strategies | |
| donations & support | • Scenario Planning & Risk Management | |
| • Public Awareness & Advocacy | ||
| ENVIRONMENTAL & SOCIAL | • Environmental Sustainability & Climate Change | |
| Climate change, diversity, and inclusion | Adaptation | |
| issues affecting operations, funding or | • Equality, Diversity & Inclusion Strategy & Action Plan | |
| sustainability | • Social Responsibility & Ethical Governance | |
| • Sustainable Operations & Financial Resilience | ||
| • Risk Monitoring & Compliance |
38
39
Complaints and Concerns
Financial Review of the Year
----- Start of picture text -----
Quality Performance Indicator 2024-2025 2025-2026
----- End of picture text -----
| Quality Performance Indicator | 2024-2025 | 2025-2026 |
|---|---|---|
| Number of complaints | 29 | 28 |
| Investigations completed, complaint upheld/partially | 28 | 25 |
| Investigations completed, complaint not upheld | 0 | 2 |
| Investigations in progress | 1 | 1 |
In 2025/26, formal complaints reduced by 3.5% (28 vs 29), with a notable improvement in retail where complaints fell significantly from 12 to 1. Most complaints related to Patient Services and Quality, reflecting core service delivery areas.
While concerns increased (18 vs 13), they mirrored complaint themes—primarily communication and service responsiveness—highlighting continued opportunities for improvement.
A total of 285 compliments were received this year. Feedback continues to consistently highlight staff kindness, compassion and dedication.
Complaints, together with feedback and consistent themes provide assurance of high-quality care, while reinforcing a continued focus on communication and responsiveness across inpatient and community services.
During the year, North London Hospice continued to provide compassionate, specialist care to patients and families across our communities, despite a challenging financial environment.
The Hospice recorded a net operating deficit of £1.3 million, reflecting the growing gap between the cost of delivering our services and the income we receive. This is a challenge faced across the hospice sector. Importantly, we have been able to manage this position through careful planning and by drawing on our reserves, ensuring that our services to patients have not been impacted.
This deficit was substantially reduced by an investment gain of £1.1m.
How We Are Funded
We are incredibly grateful for the continued support we receive from our supporters, partners and local communities.
Income from the NHS increased significantly this year to around £6 million, reflecting growing recognition of the vital role hospices play within the healthcare system. We also received £1 million of government capital funding to support investment in our facilities and services.
Fundraising income increased to over £2.8 million, thanks to the generosity of donors, volunteers and supporters. This support continues to make a real difference to the care we are able to provide.
This year we received £0.5 million in legacies, substantially lower than the prior year and the 10year average. We are investing in legacy marketing and administration and will continue to benchmark performance against other hospices and the wider charity sector.
Our network of charity shops and trading activities also plays an important role in funding our work and produced an income of over £4m. This continues to be an area of significant investment for the Charity, with new shop openings planned and continued aggressive targets for gift aid sales, with an increased contribution expected in 26/27.
How We Use Our Funds
The vast majority of our spending continues to be directed towards delivering care.
In total, we spent over £12 million on hospice services, supporting patients at home, in the community, and in our Inpatient Unit.
This cannot be achieved without a significant investment in staff – with £3 in every £4 spent being on staff costs. We are proud of the contribution our staff make to delivering patient care and we will continue to ensure resources are deployed in the right area and reflect the need of the communities we serve.
We also benefit enormously from the contribution of around 600 volunteers, whose time and support make an invaluable difference – we simply could not function without them.
Our Financial Strength
The hospice remains financially strong overall, with an asset base of around £27m, which support both our day-to-day operations and long-term sustainability, with 80% of this held in long-term assets.
We carefully manage our reserves to ensure we can continue to provide care into the future. This includes setting aside funds to:
-
manage fluctuations in legacy income
-
invest in our buildings and services
-
support future innovation and development
Cash and Sustainability
With a planned refurbishment of the Inpatient Unit taking place in 26/27, we have transferred some of our assets into liquid investments. While the majority of the investment in the new Inpatient Unit will be funded by external sources, North London Hospice’s cash contribution is now ring-fenced and will be reviewed in conjunction with the ongoing current Capital Appeal.
40
41
While this approach is sustainable in the short The hospice’s charitable purpose is enshrined in term, it underlines an important point: the cost the wording of the hospice’s objects. of hospice care continues to exceed the funding The trustees ensure that this purpose is carried available, and this is a long-term challenge we Contents out for the public benefit by delivering services and the wider hospice sector must address. that are valued by our patients, their families The Executive and the trustees are focused on a and friends and the community in general. transition to a balanced budget by 2028/29.
We continue to engage with the ICB for a fair, multi-year agreement and will carry on investing in commercial and fundraising opportunities where they offer genuine long-term value. Additionally, we will continue to review all areas of expenditure, to ensure government and donor money is spent wisely and impactfully.
Patients will continue to remain at the heart of everything we do.
Public Benefit Statement
The trustees confirm that they have complied with the duty in section 17 of the Charities Act 2011 to have due regard to the Charity Commission’s general guidance on public benefit, “Charities and Public Benefit.”
Hospice services are available to those most in need of the services in the London boroughs of Barnet, Enfield,Haringey, Camden & Islington.
The hospice provides specialist palliative care via our Inpatient Unit, in the community setting and through our Living Well service.
Disclosure of Information to the Auditor
As far as the trustees are aware, there is no relevant information of which the company’s auditor is unaware.
The trustees have taken all the steps that they ought to have taken as trustees to make themselves aware of any relevant audit information and to establish that the company’s auditor is aware of that information.
North London Hospice’s objects comply directly with two of the Charities Act’s descriptions of “charitable purpose”:
-
“the advancement of health” and
-
“the relief of those in need, by reason of youth, age, ill-health, disability, financial hardship or other disadvantage”
Approved by the Board of Trustees on 21 July 2026 and signed on its behalf by:
SIMON MORRIS MBE Chair of Trustees
ANDREW J. HARRIS Company Secretary and Honorary Treasurer
42
43
Contents
Our Trustees
----- Start of picture text -----
Name Committee Membership
Chair of the Board Development & Remuneration Committee
Simon Morris MBE - Chair Member of the Finance & External Audit and Fundraising &
Communications Committees
Chair of the People & Organisational Development Committee
Tom Easterling - Vice Chair Member of the Finance & External Audit and Board Development &
Remuneration Committees
Andrew Harris
Chair of the Finance & External Audit and Retail Committees Member of
Hononary Treasurer and
the Board Development & Remuneration Committee
Company Secretary
Anna Bokobza Member of the Finance & External Audit Committee
Saurabh Khare Member of the Retail Committee
Simon Males Member of the Finance & External Audit and Fundraising Committees
(retired July 2025) (Adviser to the Finance & External Audit Committee from July 2025)
John Reid Chair of the Inpatient Unit Redevelopment Project Board
Dr Ujjal Sarkar Member of the Clinical Governance & Assurance Committee
Member of the People & Organisational Development and Clinical
Beverley Taylor Governance & Assurance Committees
Freedom to Speak up Guardian
Chair of the Clinical Governance & Assurance Committee
Dr Cate Woodwark
Member of the Board Development & Remuneration Committee
Sam Durling Member of the People & Organisational Development Committee
Rob Tobin Member of the Clinical Governance & Assurance Committee
Suzanne Joels Member of the Clinical Governance & Assurance Committee
Marsha Jones Member of the Clinical Governance & Assurance Committee
Sam Shaerf
Member of the Retail Committee
Hayley Pannick Chair of the Fundraising & Communications Committee
Member of the Board Development & Remuneration Committee
----- End of picture text -----
Our Executive Team
----- Start of picture text -----
Name
Declan Carroll Chief Executive Officer
Dr Sam Edward Medical Director and Consultant
Wolfie Smith Director of Patient Services and Quality (left April 2026)
Anna Cooper Director of Fundraising & Communications
Kelvin Walker Director of Finance and Resources
Suzie Long Director of People and Culture
Peter Brook Commercial Director
Registered Office North London Hospice
47 Woodside Avenue, London N12 8TT
Buzzacott Audit LLP
External Auditor Chartered Accountants and Statutory Auditors
130 Wood Street
London EC2V 6DL
Barclays Bank p.l.c.
Bankers Barnet & Hampstead Business Banking
PO Box 12820
London N20 0WE
Newton Investment Management Limited
Investment The Bank of New York Mellon Centre
Managers 160 Queen Victoria Street,
London EC4V 4LA
Cazenove Capital
1 London Wall Place
London EC27 5AU
----- End of picture text -----
44
45
Independent Auditors Report to the Members of North London Hospice Contents
Opinion
We have audited the financial statements of North London Hospice (the 'charitable company') for the year ended 31st March 2026 which comprise the statement of financial activities, the balance sheet and the statement of cash flows, the principal accounting policies and the notes to the financial statements. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 "The Financial Reporting Standard Applicable in the UK and Republic of Ireland" (United Kingdom Generally Accepted Accounting Practice).
Matters on which we are required to report by exception
In the light of the knowledge and understanding of the charitable company and its environment obtained in the course of the audit, we have not identified material misstatements in the trustees' report including the strategic report. We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:
-
adequate accounting records have not been kept by the charitable company, or returns adequate for our audit have not been received from branches not visited by us; or
-
the financial statements are not in agreement with the accounting records and returns; or
-
certain disclosures of trustees' remuneration specified by law are not made; or
we have not received all the information and explanations we require for our audit.
Responsibilities of trustees
In our opinion, the financial statements:
-
give a true and fair view of the state of the charitable company's affairs as at 31st March 2026 and of its income and expenditure for the year then ended;
-
have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
-
have been prepared in accordance with the requirements of the Companies Act 2006.
Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the charitable company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Conclusions relating to going concern
In auditing the financial statements, we have concluded that the trustees’ use of the going concern basis of accounting in the preparation of the financial statements is appropriate.
Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the charitable company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.
Our responsibilities and the responsibilities of the trustees with respect to going concern are described in the relevant sections of this report.
Other information
The other information comprises the information included in the trustees' annual report, including the trustees' report, strategic report and the impact report, other than the financial statements and our auditor’s report thereon. The trustees are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.
Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.
We have nothing to report in this regard.
As explained more fully in the trustees' responsibilities statement, the trustees (who are also the directors of the charitable company for the purposes of company law) are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the trustees determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.
In preparing the financial statements, the trustees are responsible for assessing the charitable company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the trustees either intend to liquidate the charitable company or to cease operations, or have no realistic alternative but to do so.
Auditor's responsibilities for the audit of the accounts
Our objectives are to obtain reasonable assurance about whether the financial statements, as a whole, are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users, taken on the basis of these financial statements.
Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud, is detailed below:
How the audit was considered capable of detecting irregularities including fraud
Our approach to identifying and assessing the risks of material misstatement in respect of irregularities, including fraud and non-compliance with laws and regulations, was as follows:
-
The engagement partner ensured that the engagement team collectively had the appropriate competence, capabilities and skills to identify or recognise non-compliance with applicable laws and regulations;
-
- We identified the laws and regulations applicable to the charity through discussions with management and trustees and from our knowledge and experience of the charity sector;
-
We focused on specific laws and regulations which we considered may have a direct material effect on the accounts or the activities of the charity. These included but were not limited to the Companies Act 2006; the Charities Act 2011; Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable to the United Kingdom and Republic of Ireland (FRS 102) (effective 1 January 2019), legislation and regulations specific to Hospices (including the Care Quality Commission), Safeguarding Regulations, GDPR, fundraising regulations; and
-
We assessed the extent of compliance with laws and regulations identified above by making enquiries of management and representatives of the trustees and review of the minutes of trustees’ meetings.
Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
Continued……
-
the information given in the trustees' report, which is also the directors' report for the purposes of company law and includes the strategic report, for the financial year for which the financial statements are prepared is consistent with the financial statements; and
-
the trustees' report, which is also the directors' report for the purposes of company law and includes the strategic report, has been prepared in accordance with applicable legal requirements.
Continued……
46
47
INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF NORTH LONDON HOSPICE (Continued) How the audit was considered capable of detecting irregularities including fraud (continued) ~~Content~~ s We assessed the susceptibility of the charity’s accounts to material misstatement, including how fraud might occur by:
-
Making enquiries of management and representatives of the trustees as to where they considered there was susceptibility to fraud, their knowledge of actual, suspected and alleged fraud; and
-
Considering the internal controls in place to mitigate risks of fraud and non-compliance with laws and regulations.
To address the risk of fraud through management bias and override of controls, we:
-
Performed analytical procedures to identify any unusual or unexpected relationships;
-
Tested and reviewed journal entries to identify unusual transactions;
-
Verified the implementation of financial controls;
-
Assessed whether judgements and assumptions made in determining the accounting estimates were indicative of potential bias; and
-
Investigated the rationale behind significant or unusual transactions.
In response to the risk of irregularities and non-compliance with laws and regulations, we designed procedures which included, but were not limited to:
-
Agreeing accounts disclosures to underlying supporting documentation;
-
Reading the minutes of meetings of trustees; and
-
Enquiring of as to actual and potential litigation and claims.
There are inherent limitations in our audit procedures described above. The more removed that laws and regulations are from financial transactions, the less likely it is that we would become aware of non-compliance. Auditing standards also limit the audit procedures required to identify non-compliance with laws and regulations to enquiry of the trustees and other management and the inspection of regulatory and legal correspondence, if any.
Material misstatements that arise due to fraud can be harder to detect than those that arise from error as they may involve deliberate concealment or collusion.
A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council’s website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor’s report.
Use of our report
This report is made solely to the charitable company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the charitable company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the charitable company and the charitable company's members as a body, for our audit work, for this report, or for the opinions we have formed.
17 August 2026
Edward Finch (Senior Statutory Auditor) for and on behalf of Buzzacott Audit LLP, Statutory Auditor
130 Wood Street London EC2V 6DL
NORTH LONDON HOSPICE
STATEMENT OF FINANCIAL ACTIVITIES, INCLUDING THE INCOME AND EXPENDITURE ACCOUNT
| FOR THE YEAR ENDED: Unrestricted Note funds Income: Donations and fundraising 2,173,974 Legacies 531,521 Charitable activities Grants 4 5,964,666 Other trading activities Charity shops sales 2,235,437 Donated agency sales 1,815,905 Rental income 13,800 Investment income 5 483,773 Other 6 105,397 Total income 13,324,473 Expenditure: Raising funds Fundraising and promotion 7 1,345,670 Charity shops expenditure 8 3,012,904 Investment manager's fees 29,341 Charitable activities Cost of operation of hospice 9 11,877,651 Total expenditure 16,265,566 Net gains on investments 13 1,113,888 Net (expenditure)/income before transfers (1,827,205) Transfers between funds 1,170,781 Net movement in funds (656,424) Reconciliation of funds: Total funds brought forward, 1st April 2025 25,888,151 Total funds carried forward, 31st March 2026 £ 25,231,727 |
31ST MARCH 2026 | 31ST MARCH 2026 | 31ST MARCH 2026 | 2025 | ||||
|---|---|---|---|---|---|---|---|---|
| Restricted funds 645,092 - 1,144,065 - - - - - |
Endowment fund - - - - - - - - |
Total funds 2,819,066 531,521 7,108,731 2,235,437 1,815,905 13,800 483,773 105,397 |
Total funds 2,515,238 939,743 6,598,346 2,939,328 1,255,341 13,800 403,892 74,495 |
|||||
| 13,324,473 | 1,789,157 | - | 15,113,630 | 14,740,183 | ||||
| 1,345,670 3,012,904 29,341 11,877,651 |
- - - 170,946 |
- - - - |
1,345,670 3,012,904 29,341 12,048,597 |
1,542,169 2,741,939 66,595 12,264,037 |
||||
| 16,265,566 | 170,946 | - | 16,436,512 | 16,614,740 | ||||
| 1,113,888 | - | - | 1,113,888 | 355,048 | ||||
| (1,827,205) 1,170,781 |
1,618,211 (1,170,781) |
- - |
(208,994) - |
(1,519,509) - |
||||
| (656,424) 25,888,151 |
447,430 1,344,849 |
- 150,000 |
(208,994) 27,383,000 |
(1,519,509) 28,902,509 |
||||
| 1,792,279 | 150,000 | 27,174,006 | 27,383,000 |
All incoming resources and resources expended derive from continuing activities.
The statement of financial activities includes all gains and losses recognised in the year.
The detailed comparative information for the statement of financial activities is included at note 23. The attached notes form part of these accounts.
48
49
STATEMENTS OF CASH FLOWS
| ~~Contents~~ NORTH LONDON HOSPICE BALANCE SHEET Note 2026 Fixed assets: Tangible assets 12 9,135,105 Investments 13 13,347,340 Total fixed assets 22,482,445 Current assets: Debtors 14 2,067,174 Cash at bank and in hand 5,318,917 Total current assets 7,386,091 Liabilities: Creditors: amounts falling due within one year 15 (2,694,530) Net current assets 4,691,561 Total assets less current liabilities 27,174,006 Total net assets £ 27,174,006 The funds of the charity: Endowment fund 16 150,000 Restricted income funds 17 1,792,279 Unrestricted funds Designated funds 18 13,985,105 General Fund 19 11,246,622 Total charity funds £ 27,174,006 31ST MARCH |
NORTH LONDON HOSPICE | ~~nts~~ 31ST MARCH |
~~nts~~ 31ST MARCH |
|
|---|---|---|---|---|
| 2025 8,204,531 13,453,555 |
||||
| 21,658,086 | ||||
| 2,766,145 4,272,123 |
||||
| 7,038,268 (1,313,354) |
||||
| 5,724,914 | ||||
| 27,383,000 | ||||
| 27,383,000 | ||||
| 150,000 1,344,849 13,054,531 12,833,620 |
||||
| 27,383,000 |
Approved for issue by the Board of Trustees on 21st July 2026 and signed on its behalf by:-
SIMON B. MORRIS (Chair)
NORTH LONDON HOSPICE
| FOR THE YEAR ENDED: Net cash provided by/(used in) operating activities Cash flows from investing activities Investment income Income from UK listed investments Interest receivable Purchases of tangible fixed assets Purchases of fixed asset investments Proceeds from disposals of fixed asset investments Cash from investing activities Increase in cash and cash equivalents in the year Cash and cash equivalents at the beginning of the year Cash and cash equivalents at the end of the year £ Reconciliation of net movement in funds to net cash flow from operating activities Net movement in funds Investment income Income from UK listed investments Interest receivable Depreciation Net gains on investments Decrease in debtors Increase/(decrease) in creditors Net cash provided by/(used in) operating activities £ Analysis of cash and cash equivalents Bank accounts Cash in hand Total £ Analysis of changes in net funds At start of year Cash at bank and in hand £ 4,272,123 |
31ST MARCH | ||||
| 2025 (1,827,361) |
|||||
| 372,276 31,616 (422,448) (372,276) 4,000,000 |
|||||
| 3,609,168 | |||||
| 1,781,807 2,490,316 |
|||||
| 4,272,123 | |||||
| (1,519,509) (372,276) (31,616) 555,272 (355,048) 939,789 (1,043,973) |
|||||
Net movement in funds Investment income Income from UK listed investments Interest receivable Depreciation Net gains on investments Decrease in debtors Increase/(decrease) in creditors Net cash provided by/(used in) operating activities Analysis of cash and cash equivalents Bank accounts Cash in hand Total Analysis of changes in net funds Cash at bank and in hand £ |
|||||
| (1,827,361) | |||||
| 4,269,876 2,247 |
|||||
| 4,272,123 | |||||
| At end of year 5,318,917 |
ANDREW J. HARRIS (Treasurer) The attached notes form part of these accounts.
50
51
NORTH LONDON HOSPICE
ACCOUNTING POLICIES FOR THE YEAR ENDED 31ST MARCH 2026 ~~Contents~~
ACCOUNTING POLICIES FOR THE YEAR ENDED 31ST MARCH 2026 (Continued)
Company information
North London Hospice is a company limited by guarantee incorporated in England and Wales. The registered office is 47 Woodside Avenue, London, N12 8TF.
a) Basis of preparation of accounts and assessment of going concern
The accounts have been prepared under the historical cost convention with the exception of investments which are included at their market value. The accounts have been prepared in accordance with the Statement of Recommended Practice: Accounting and Reporting by Charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) issued in October 2019, the Companies Act 2006 and Charities Act 2011.
The accounts are prepared in sterling, which is the functional currency of the company, and are rounded to the nearest £1.
Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy notes.
The trustees have prepared the accounts on the going concern basis which assumes the charitable company will continue in operational existence for the foreseeable future as the trustees consider that there are no material uncertainties about the charity’s ability to continue as a going concern. The level of reserves held mean that the trustees expect the charity to be able to continue its activities for a period of at least 12 months from the approval of these accounts.
North London Hospice meets the definition of a public benefit entity under FRS 102.
b) Fund accounting
General funds are unrestricted funds which are available for use at the discretion of the trustees in furtherance of the general objectives of the charity and which have not been designated for other purposes.
Designated funds comprise unrestricted funds that have been set aside by the trustees for particular purposes. The aim and use of each designated fund is set out in the notes to the accounts.
Restricted funds are funds which are to be used in accordance with specific restrictions imposed by donors or which have been raised by the charity for particular purposes. The costs of raising and administering such funds are charged against the specific fund. The aim and use of each restricted fund is set out in the notes to the accounts.
c) Income (continued)
Grant and service level agreement income is recognised in the period to which the income relates.
Income from investments has been taken into the accounts when receivable. Interest receivable has been accounted for on an accruals basis.
d) Expenditure and irrecoverable value added tax
Expenditure is recognised once there is a legal or constructive obligation to make payment to a third party, it is probable that settlement will be required and the amount of the obligation can be measured reliably.
All expenditure is accounted for on an accruals basis. Staff and other costs are allocated directly to the activity for which they are incurred. Costs of raising funds comprises the costs associated with attracting voluntary income and the costs of operating the charity's shops.
Charitable activities expenditure comprises those costs incurred in the delivery of hospice services. It includes both costs that can be directly allocated and those of an indirect nature necessary to support them including governance costs.
Not all value added tax is recoverable. Irrecoverable VAT is charged against the expenditure heading for which it was incurred.
e) Capitalisation and depreciation
The trustees have adopted the policy that small items of expenditure, being those less than £1,000, of a capital nature are not capitalised but are included in resources expended.
Freehold land is not depreciated. Tangible fixed assets are stated at cost less depreciation. Depreciation is provided at rates calculated to write off the cost of fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
| ulated to write off the cost of n the following bases: |
fixed | assets, less their e |
|---|---|---|
| Freehold buildings | - | 2% straight-line |
| Furniture, fixtures, fittings and | ||
| medical equipment | - | 20% straight-line |
| Motor vehicles | - | 25% straight-line |
| Refurbishment | - | 10% straight-line |
f) Investments
Endowment funds are capital funds that must be retained for the benefit of the charity. The use of income arising from these capital sums may be subject to restrictions.
Investment income, gains and losses are allocated to the appropriate fund.
c) Income
All income is recognised once the charity has entitlement to the income, it is probable that the income will be received and the amount of income receivable can be measured reliably.
For legacies, entitlement is taken as the earlier of the date on which either: the charity is aware that probate has been granted, the estate has been finalised and notification has been made by the executor to the Trust that a distribution will be made, or when a distribution is received from the estate. Receipt of a legacy, in whole or in part, is only considered probable when the amount can be measured reliably and the charity has been notified of the executor's intention to make a distribution. Where legacies have been notified to the charity, or the charity is aware of the granting of probate, and the criteria for income recognition have not been met, then the legacy is treated as a contingent asset and disclosed if material.
Investments are a form of basic financial instrument and are initially recognised at their transaction value and subsequently measured at their fair value as at the balance sheet date using the closing quoted market price. The statement of financial activities includes the net gains and losses arising on revaluation and disposals throughout the year.
The charity does not acquire put options, derivatives or other complex financial instruments.
The main form of financial risk faced by the charity is that of volatility in equity markets and investment markets due to wider economic conditions, the attitude of investors to investment risk, and changes in sentiment concerning equities and within particular sectors or sub sectors.
g) Stocks
Stocks of donated goods to fundraising shops are not reflected in the accounts because the trustees consider it is impracticable to be able to assess the value of donated goods until sale as there are no systems in place which record these items until they are sold and undertaking a stock take would incur undue cost for the charity which far outweighs the benefits.
52
53
NORTH LONDON HOSPICE
NORTH LONDON HOSPICE ACCOUNTING POLICIES FOR THE YEAR ENDED 31ST MARCH 2026 (Continued) ~~Contents~~
ACCOUNTING POLICIES FOR THE YEAR ENDED 31ST MARCH 2026 (Continued)
h) Debtors
Trade and other debtors are recognised at the settlement amount after any trade discount offered. Prepayments are valued at the amount prepaid.
i) Cash at bank and in hand
Cash at bank and in hand includes cash and short term highly liquid investments with a short maturity of three months or less from the date of acquisition or opening of the deposit or similar account.
j) Creditors and provisions
Creditors and provisions are recognised where the charity has a present obligation resulting from a past event that will probably result in the transfer of funds to a third party and the amount due to settle the obligation can be measured or estimated reliably. Creditors and provisions are normally recognised at their settlement amount after allowing for any trade discounts due.
k) Financial instruments
The charity only has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value.
NOTES TO THE ACCOUNTS - 31ST MARCH 2026
1. Legal status
North London Hospice is a company limited by guarantee and has no share capital. It is registered in England and Wales. The members of the company are the trustees named on page 44, of which there were 15 at 31st March 2026 (2025 - 16). In the event of the company being wound up, the liability in respect of the guarantee is limited to £1 per member of the company.
2. Judgements in applying accounting policies and key sources of estimation uncertainty
In the application of the charity's accounting policies, the trustees are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised, if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.
Key sources of estimation uncertainty
The annual depreciation charge for tangible fixed assets is sensitive to changes in the estimated useful economic lives and residual values of the assets. The useful economic lives and residual values are re-assessed annually. They are amended when necessary to reflect current estimates, based on technological advancement, future investments, economic utilisation and the physical condition of the assets. See note 12 for the carrying amount of the tangible fixed assets and accounting policy e) for the useful economic lives for each class of asset.
3. Group accounts
l) Pensions
The charity contributes to defined benefit and defined contribution schemes on behalf of its employees.
The charity has one wholly owned subsidiary company, North London Hospice (Trading) Limited. Group accounts have not been prepared as the subsidiary company is dormant and not material in the context of the group. Accordingly, these accounts present information about the charity as an individual entity and not about its group.
The assets of the defined benefit scheme are held separately from those of the Hospice by the National Health Service Superannuation Scheme.
The assets of the National Health Service Superannuation Scheme cannot be identified on a consistent and reasonable basis. Contributions to the scheme are charged to the statement of financial activities so as to spread the cost of pensions over employees' working lives with the charity. The contributions are determined by qualified actuaries on the basis of periodic valuations.
Defined contribution scheme pension costs charged in the accounts represent the amounts payable to the scheme in respect of the year. Where employees' wages and salaries are allocated to unrestricted or restricted funds, the pension costs relating to those employees, and any associated liabilities, are allocated to the same funds.
m) Operating leases
Rental costs under operating leases are charged in the accounts in equal annual instalments over the period of the leases.
54
55
NOTES TO THE ACCOUNTS - 31ST MARCH 2026 (Continued) ~~Content~~ s
| 4. 5. |
Unrestricted funds Grants Year ended 31st March 2026 North Central London - Integrated Care Board Barnet/Enfield/Haringey 5,964,666 DHSC Capital Grant - £ 5,964,666 Year ended 31st March 2025 North Central London - Integrated Care Board Barnet/Enfield/Haringey 4,890,760 North Middlesex Hospital NHS Trust - DHSC Capital Grant - Peabody Grant - £ 4,890,760 Investment income Year ended 31st March 2026 Income from UK listed investments 429,240 Interest receivable 54,533 £ 483,773 Year ended 31st March 2025 Income from UK listed investments 284,102 Interest receivable 31,616 £ 315,718 |
Unrestricted funds 5,964,666 - |
Restricted funds - 1,144,065 |
Endowment funds - - |
Endowment funds - - |
Total 5,964,666 1,144,065 |
|---|---|---|---|---|---|---|
| 1,144,065 | - | 7,108,731 | ||||
| 4,890,760 - - - |
- 922,868 284,718 500,000 |
- - - - |
4,890,760 922,868 284,718 500,000 |
|||
| 1,707,586 | - | 6,598,346 | ||||
| 429,240 54,533 |
- - |
- - |
429,240 54,533 |
|||
| - | - | 483,773 | ||||
| 284,102 31,616 |
- - |
88,174 - |
372,276 31,616 |
|||
| - | 88,174 | 403,892 |
| 6. 7. 8. |
Unrestricted funds Other income Year ended 31st March 2026 Education income 48,320 Work placement 57,077 £ 105,397 Year ended 31st March 2025 Education income 43,822 Work placement 27,380 Apprenticeship levy top up 3,293 £ 74,495 Fundraising and promotion Year ended 31st March 2026 Staff costs 949,057 Other costs 396,613 £ 1,345,670 Year ended 31st March 2025 Staff costs 981,344 Other costs 560,825 £ 1,542,169 Charity shops expenditure Year ended 31st March 2026 Staff costs 1,851,630 Other costs 512,705 Rents paid under operating leases 605,752 Rates and water 42,817 £ 3,012,904 Year ended 31st March 2025 Staff costs 1,720,185 Other costs 432,318 Rents paid under operating leases 556,952 Rates and water 32,484 £ 2,741,939 |
Unrestricted funds 48,320 57,077 |
Unrestricted funds 48,320 57,077 |
Restricted funds - - |
Restricted funds - - |
Endowment funds - - |
Endowment funds - - |
Total 48,320 57,077 |
|
|---|---|---|---|---|---|---|---|---|---|
| 105,397 | - | - | 105,397 | ||||||
| 43,822 27,380 3,293 |
- - - |
- - - |
43,822 27,380 3,293 |
||||||
| 74,495 | - | - | 74,495 | ||||||
| 949,057 396,613 |
- - |
- - |
949,057 396,613 |
||||||
| - | - | 1,345,670 | |||||||
| 981,344 560,825 |
- - |
- - |
981,344 560,825 |
||||||
| - | - | 1,542,169 | |||||||
| 1,851,630 512,705 605,752 42,817 |
- - - - |
- - - - |
1,851,630 512,705 605,752 42,817 |
||||||
| - | - | 3,012,904 | |||||||
| 1,720,185 432,318 556,952 32,484 |
- - - - |
- - - - |
1,720,185 432,318 556,952 32,484 |
||||||
| - | - | 2,741,939 |
56
57
NOTES TO THE ACCOUNTS - 31ST MARCH 2026 (Continued) ~~Contents~~
| 9. | Unrestricted funds Cost of operation of hospice Year ended 31st March 2026 Direct costs Hospice staff costs 7,039,764 Catering and cleaning services 559,436 Other medical costs 284,792 Support costs Support staff costs 1,812,372 Premises costs 529,443 Other costs 978,348 Depreciation 647,728 Governance costs (see Note 10) 25,768 £ 11,877,651 Year ended 31st March 2025 Direct costs Hospice staff costs 4,592,690 Catering and cleaning services 570,172 Other medical costs 381,739 Support costs Support staff costs 1,772,615 Premises costs 631,919 Other costs 856,634 Depreciation 555,272 Governance costs (see Note 10) 31,338 £ 9,392,379 |
Unrestricted funds 7,039,764 559,436 284,792 1,812,372 529,443 978,348 647,728 25,768 |
Restricted funds 166,610 - 4,252 - 84 - - - |
Restricted funds 166,610 - 4,252 - 84 - - - |
Endowment funds - - - - - - - - |
Endowment funds - - - - - - - - |
Total 7,206,374 559,436 289,044 1,812,372 529,527 978,348 647,728 25,768 |
|
|---|---|---|---|---|---|---|---|---|
| 170,946 | - | 12,048,597 | ||||||
| 4,592,690 570,172 381,739 1,772,615 631,919 856,634 555,272 31,338 |
997,168 - 4,294 - 1,608 - - - |
1,868,588 - - - - - - - |
7,458,446 570,172 386,033 1,772,615 633,527 856,634 555,272 31,338 |
|||||
| 1,003,070 | 1,868,588 | 12,264,037 |
Support costs including governance costs incurred relating to fundraising and promotion and charity shops are immaterial. Consequently all support costs are included in the cost of operation of hospice.
| Unrestricted funds Governance costs Year ended 31st March 2026 Auditors' remuneration Current year 18,100 Accountancy fees 6,476 Legal & professional fees 1,192 £ 25,768 Year ended 31st March 2025 Auditors' remuneration Current year 16,200 Accountancy fees 9,385 Legal & professional fees 5,753 £ 31,338 |
Unrestricted funds 18,100 6,476 1,192 |
Unrestricted funds 18,100 6,476 1,192 |
Restricted funds - - - |
Restricted funds - - - |
Endowment funds - - - |
Endowment funds - - - |
Total 18,100 6,476 1,192 |
|
|---|---|---|---|---|---|---|---|---|
| 25,768 | - | - | 25,768 | |||||
| 16,200 9,385 5,753 |
- - - |
- - - |
16,200 9,385 5,753 |
|||||
| 31,338 | - | - | 31,338 |
10. Governance costs
- Staff costs, trustee remuneration and expenses and the cost of key management personnel
| Staff costs, trustee remuneration and expenses and the cost of key management personnel | nel | |
|---|---|---|
| 2026 Wages and salaries 10,061,833 Social security costs 1,150,603 Pension costs 527,414 Redundancy costs 79,583 11,819,433 £ |
2026 10,061,833 1,150,603 527,414 79,583 |
2025 10,255,280 979,747 569,096 128,467 |
| 11,932,590 |
The charity operates both defined benefit and defined contribution schemes for its employees, the pension charge for the year is shown above. At the balance sheet date £74,075 (2025 - £78,518) was accrued for pension costs.
Analysis by function:
| Analysis by function: | ||||
|---|---|---|---|---|
| Hospice services Fundraising and promotion Shops Support The number of higher paid employees was: £60,000 to £70,000 £70,000 to £80,000 £80,000 to £90,000 £90,000 to £100,000 £120,000 to £130,000 £ |
7,206,374 949,057 1,851,630 1,812,372 |
7,458,446 981,344 1,720,185 1,772,615 |
||
| 11,819,433 | 11,932,590 | |||
| 2026 Number 13 7 2 2 1 |
2025 Number 12 7 3 1 1 |
58
59
NOTES TO THE ACCOUNTS - 31ST MARCH 2026 (Continued) Staff costs, trustee remuneration and expenses and the cost of key management personnel (continued) ~~Content~~ s
11. Staff costs, trustee remuneration and expenses and the cost of key management personnel (continued)
Contributions were made to a defined benefit scheme for fourteen (2025 - sixteen) higher paid employees and to a defined contribution scheme for eleven (2025 - nine) higher paid employees. Total contributions in the year amounted to £151,985 (2025 - £149,810).
No trustees have received any remuneration in respect of their services or had any expenses reimbursed (2025 - the same).
The average number of employees, analysed by function, was:
| The average number of employees, analysed by function, was: | ||||
|---|---|---|---|---|
| Hospice services Fundraising and promotion Shops Support |
2026 Number 103 20 54 51 |
2025 Number 110 19 50 55 |
||
| 228 | 234 |
The average number of employees reflects the average actual number of employees rather than the average full-time equivalents (FTE).
The staff costs and numbers of employees do not include any allowance for the work carried out for the Hospice by over 600 volunteers. Volunteers have carried out a variety of roles including welcoming visitors to the Hospice, assisting staff in the inpatient unit in serving meals, helping to transport patients to and from the Outpatients and Wellbeing Service, carrying out numerous administrative functions and helping at fundraising events, and a significant number of volunteers assist in our charity shops. The value of this work cannot be quantified.
The key management personnel of the charitable company are the trustees and the executive team, comprising the Chief Executive Officer, the Medical Director and Consultant, the Director of Patient Services, the Director of Fundraising and Communications, the Director of Finance and Resources and the Director of People and Culture. The employee benefits of the key management personnel totalled £734,622 (2025 - £724,771).
12. Tangible fixed assets
| Tangible fixed assets | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cost At 1st April 2025 Additions At 31st March 2026 Depreciation At 1st April 2025 Charge for the year At 31st March 2026 Net book values At 31st March 2026 £ At 31st March 2025 £ |
Freehold land and buildings 10,180,777 - |
Furniture, fixtures and fittings 2,773,448 191,695 |
Medical equipment 483,526 29,214 |
Motor vehicles 102,260 |
Refurbishment 2,148,390 1,369,588 |
Total 15,688,401 1,590,497 |
|||||
| 10,180,777 | 2,965,143 | 512,740 | 102,260 | 3,517,978 | 17,278,898 | ||||||
| 3,783,832 172,042 |
2,437,185 176,385 |
459,421 16,534 |
58,141 14,707 |
745,291 280,255 |
7,483,870 659,923 |
||||||
| 3,955,874 | 2,613,570 | 475,955 | 72,848 | 1,025,546 | 8,143,793 | ||||||
| 6,224,903 | 351,573 | 36,785 | 29,412 | 2,492,432 | 9,135,105 | ||||||
| 6,396,945 | 336,263 | 24,105 | 44,119 | 1,403,099 | 8,204,531 |
Freehold land and buildings includes buildings with a cost of £8,769,618 (2025 - the same) that are being depreciated.
Freehold land and buildings have not been revalued. The trustees consider that there is no advantage in obtaining a valuation as the land and buildings are used exclusively for charitable purposes.
All assets are held for charitable use.
| 13. | Fixed asset investments 2026 Listed investments: Market value at 1st April 2025 13,448,555 Additions at cost 6,869,897 Disposals at market value brought forward (or cost if later) (7,596,108) Unrealised gains adjustment at end of year 619,996 Market value at 31st March 2026 13,342,340 Cost of shares in subsidiary company: North London Hospice (Trading) Limited 5,000 £ 13,347,340 |
2026 13,448,555 6,869,897 (7,596,108) 619,996 |
2025 16,721,231 372,276 (3,727,784) 82,832 |
|---|---|---|---|
| 13,342,340 5,000 |
13,448,555 5,000 |
||
| 13,453,555 |
The historical cost of the listed investments as at 31st March 2026 was £10,416,487 (2025 - £8,328,471).
Reconciliation of unrealised gains
| Unrealised gains at 1st April 2025 5,120,084 Unrealised gains brought forward realised during year (2,814,227) Unrealised gains adjustment at end of year 619,996 Unrealised gains at 31st March 2026 £ 2,925,853 |
5,120,084 (2,814,227) 619,996 |
6,469,583 (1,432,331) 82,832 |
| 5,120,084 |
The historical cost and unrealised gains for 2025 have been restated to reflect a correction to an error identified as part of the accounts preparation process in this year.
Reconciliation of net gains on investments
| Reconciliation of net gains on investments | ||
|---|---|---|
| Proceeds from disposals of investments 8,090,000 Market value brought forward of those investments (or cost if later) (7,596,108) 493,892 Unrealised gains adjustment at end of year 619,996 Net gains on investments at 31st March 2026 £ 1,113,888 Market value £ 1,173,775.168 units in the Newton Sustainable Growth and Income Fund for Charities 2,259,517 2,385,461.199 units in the Newton Growth & Income Fund for Charities 4,662,146 8,176,712.31 units in the Cazenove Sustainable Multi-Asset Fund for Charities 6,420,677 £ 13,342,340 At 31st March 2026 UK equities comprised: At 31st March 2026 the investments all relate to pooled charity unit trusts. |
8,090,000 (7,596,108) |
4,000,000 (3,727,784) |
| 493,892 619,996 |
272,216 82,832 |
|
| 1,113,888 | 355,048 | |
| Market value £ 2,259,517 4,662,146 6,420,677 |
Cost £ 1,321,831 2,698,242 6,396,414 |
|
| 10,416,487 |
The Hospice owns 100% of the ordinary share capital of North London Hospice (Trading) Limited, a company registered in England and Wales, company number 2268094. The registered office address of North London Hospice (Trading) Limited is 47 Woodside Avenue, London, N12 8TT.
Until 31st March 2018 North London Hospice (Trading) Limited sold goods on behalf of the public for commission, following which the owners were invited to donate the proceeds to the charity under the gift aid scheme. Since 1st April 2018 this has been dealt with directly by the charity as donated agency sales.
60
61
NORTH LONDON HOSPICE
NORTH LONDON HOSPICE
NOTES TO THE ACCOUNTS - 31ST MARCH 2026 (Continued)
NOTES TO THE ACCOUNTS - 31ST MARCH 2026 (Continued) ~~Content~~ s
14. Debtors
| ~~Content~~s NORTH LONDON HOSPICE NOTES TO THE ACCOUNTS-31ST MARCH 2026 (Continued) Debtors |
s | |
|---|---|---|
| 2026 VAT recoverable 289,283 Other debtors 229,885 Prepayments and accrued income 1,548,006 2,067,174 £ |
2026 289,283 229,885 1,548,006 |
2025 215,648 557,887 1,992,610 |
| 2,766,145 |
Prepayments and accrued income includes measurable legacies committed to North London Hospice as at 31st March 2026, but which were not received by that date, amounting to £684,287 (2025 - £1,365,635).
15. Creditors: amounts falling due within one year
| Creditors: amounts falling due within one year | ||
|---|---|---|
| 2026 Expense creditors 582,597 Taxation and social security 253,394 Other creditors 261 Accruals and deferred income 1,858,278 £ 2,694,530 |
2026 582,597 253,394 261 1,858,278 |
2025 512,289 248,641 263 552,161 |
| 1,313,354 |
- Endowment fund Capital Fund Balance 1st April 2025 150,000 Income - - Expenditure Balance 31st March 2026 £ 150,000
Capital Fund:
Capital sums totalling £150,000 were received in 1993 and 1994. Income from the fund can be used for general purposes and the fund is represented by cash on deposit.
17. Restricted funds
The income funds of the charity include restricted funds comprising the following unexpended balances of donations to be applied for specific purposes:
| Pauline Glasser Fund Peabody Grant DHSC Grant Rapid Response Barnet, Enfield & Haringey Community Development Compassionate Neighbours Syringe Drivers Complementary Therapies Oxygen Concentrators Community Team Enfield Cuddle Bed Enfield Water Dispenser Physiotherapy Rapid Response Bags IPU Costs IPU Capital Start Up Fund £ |
Balance 1st April 2025 734,382 500,000 - 97,566 5,000 1,362 539 5,000 1,000 - - - - - - - |
Income - - 1,144,065 307,062 - 42,100 5,049 1,000 - 2,500 24,241 1,000 300 10,000 1,500 250,340 |
Expenditure - - - (138,015) - (26,415) (1,559) (4,957) - - - - - - - - |
Transfers between funds - - (1,144,065) - - - (2,916) - - - (22,800) (1,000) - - - - (1,170,781) |
Balance 31st March 2026 734,382 500,000 - 266,613 5,000 17,047 1,113 1,043 1,000 2,500 1,441 - 300 10,000 1,500 250,340 |
|||||
| 1,344,849 | 1,789,157 | (170,946) | 1,792,279 |
Transfers have been made from certain of the restricted funds to the unrestricted general fund since appropriate expenditure has been incurred and therefore the conditions relating to the inherent restrictions have been complied with.
62
63
~~C~~ NOTES TO THE ACCOUNTS ~~ontent~~ - 31ST MARCH 2026 (Continued) s
20. Analysis of net assets between funds
At 31st March 2026
| 18. | Designated funds Tangible Fixed Asset Fund Legacy Buffer Fund IPU Capital Start Up Fund Retail - Start Up - New Premises Fund Strategic Investment/Innovation Fund £ |
Balance 1st April 2025 8,204,531 1,500,000 2,700,000 500,000 150,000 |
Income - - - - - |
Expenditure - - - - - |
Transfers between funds 930,574 - - - - 930,574 |
Balance 31st March 2026 9,135,105 1,500,000 2,700,000 500,000 150,000 |
|||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 13,054,531 | - | - | 13,985,105 |
The trustees have designated £9,135,105 (2025 - £8,204,531) as a tangible fixed assets fund. This fund represents an amount equal to the net book value of the tangible fixed assets.
Furthermore, the trustees have designated additional funds as part of the ongoing strategic review. These include future investment in both clinical delivery (with plans for an IPU refurbishment) as well as future investment in the retail shops. Additionally, a legacy buffer fund has been created should legacy income fall below the current 10 year average.
19. General Fund
| General Fund | ||
|---|---|---|
| Balance 1st April 2025 | 12,833,620 | |
| Income | 13,324,473 | |
| Expenditure | (16,265,566) | |
| Net gains on investments | 1,113,888 | |
| Transfers from Restricted funds | 1,170,781 | |
| Transfers to Unrestricted funds | (930,574) | |
| Balance 31st March 2026 | £ | 11,246,622 |
| At 31st March 2026 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Endowment fund Capital Fund Restricted funds Pauline Glasser Fund Peabody Grant Rapid Response Barnet, Enfield & Haringey Community Development Compassionate Neighbours Syringe Drivers Complementary Therapies Oxygen Concentrators Community Team Enfield Cuddle Bed Enfield Water Dispenser Physiotherapy Rapid Response Bags IPU Costs IPU Capital Start Up Fund Unrestricted funds Designated funds Tangible Fixed Assets Fund Legacy Buffer Fund IPU Capital Start Up Fund Retail - Start Up - New Premises Fund Strategic Investment/ Innovation Fund General Fund £ |
Tangible fixed assets - - - - - - - - - - - - - - - - 9,135,105 - - - - - |
Investments - 734,382 - - - - - - - - - - - - - - - - - - - 12,612,958 |
Current assets 150,000 - 500,000 266,613 5,000 17,047 1,113 1,043 1,000 2,500 1,441 - 300 10,000 1,500 250,340 - 1,500,000 2,700,000 500,000 150,000 1,328,194 |
Creditors - - - - - - - - - - - - - - - - - - - - - (2,694,530) |
Total 150,000 734,382 500,000 266,613 5,000 17,047 1,113 1,043 1,000 2,500 1,441 - 300 10,000 1,500 250,340 9,135,105 1,500,000 2,700,000 500,000 150,000 11,246,622 |
||||
| 9,135,105 | 13,347,340 | 7,386,091 | (2,694,530) | 27,174,006 |
At 31st March 2025
| At 31st March 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Endowment fund Capital Fund Restricted funds Pauline Glasser Fund Peabody Grant Rapid Response Rapid Response Barnet Rapid Response Enfield & Haringey Community Development Compassionate Neighbours Syringe Drivers Complementary Therapies Oxygen Concentrators Unrestricted funds Designated funds Tangible Fixed Assets Fund Legacy Buffer Fund IPU Capital Start Up Fund Premises Fund Innovation Fund General Fund £ |
Tangible fixed assets - - - - - - - - - - - 8,204,531 - - - - - |
Investments - 734,382 - - - - - - - - - - - - - - 12,719,173 |
Current assets 150,000 - 500,000 61,600 30,966 5,000 5,000 1,362 539 5,000 1,000 - 1,500,000 2,700,000 500,000 150,000 1,427,801 |
Creditors - - - - - - - - - - - - - - (1,313,354) |
Total 150,000 734,382 500,000 61,600 30,966 5,000 5,000 1,362 539 5,000 1,000 8,204,531 1,500,000 2,700,000 500,000 150,000 12,833,620 |
||||
| 8,204,531 | 13,453,555 | 7,038,268 | (1,313,354) | 27,383,000 |
64
65
NORTH LONDON HOSPICE
NOTES TO THE ACCOUNTS - 31ST MARCH 2026 (Continued)
NOTES TO THE ACCOUNTS - 31ST MARCH 2026 (Continued) ~~Content~~ s
21. Commitments under operating leases
The company is committed to make the following future minimum lease payments under non-cancellable operating leases for the use of land and buildings:
| for the use of land and buildings: | ||||
|---|---|---|---|---|
| Payable within one year Payable within two to five years Payable in more than five years £ |
2026 659,611 1,282,248 570,618 2,512,477 |
2025 460,904 1,182,107 195,089 |
||
| 1,838,100 |
22. Related party transactions
During the year payments were made to Pallicare Limited, a company whose director is the wife of trustee Ujjal Sarker, totalling £12,712 (2025 - £11,600).
The total amounts of donations received from the trustees and their related parties during the year was £2,295 (2025 - £800).
23. Prior year's statement of financial activities
| Prior year's statement of financial activities | ||||||
|---|---|---|---|---|---|---|
| Unrestricted funds Income: Donations and fundraising 2,320,618 Legacies 939,743 Charitable activities Grants 4,890,760 Other trading activities Charity shops sales 2,939,328 Donated agency sales 1,255,341 Rental income 13,800 Investment income 315,718 Other 74,495 Total income 12,749,803 Expenditure: Raising funds Fundraising and promotion 1,542,169 Charity shops expenditure 2,741,939 Investment manager's fees 66,595 Charitable activities Cost of operation of hospice 9,392,379 Total expenditure 13,743,082 Net gains on investments 279,942 Net income before transfers (713,337) Transfers between funds 1,171,921 Net movement in funds 458,584 Reconciliation of funds: Total funds brought forward, 1st April 2024 25,429,567 Total funds carried forward, 31st March 2025 £ 25,888,151 |
Unrestricted funds 2,320,618 939,743 4,890,760 2,939,328 1,255,341 13,800 315,718 74,495 |
Restricted funds 194,620 - 1,707,586 - - - - - |
Endowment funds - - - - - - 88,174 - |
Total funds 2,515,238 939,743 6,598,346 2,939,328 1,255,341 13,800 403,892 74,495 |
||
| 12,749,803 | 1,902,206 | 88,174 | 14,740,183 | |||
| 1,542,169 2,741,939 66,595 9,392,379 |
- - - 1,003,070 |
- - - 1,868,588 |
1,542,169 2,741,939 66,595 12,264,037 |
|||
| 13,743,082 | 1,003,070 | 1,868,588 | 16,614,740 | |||
| 279,942 | - | 75,106 | 355,048 | |||
| (713,337) 1,171,921 |
899,136 439,351 |
(1,705,308) (1,611,272) |
(1,519,509) - |
|||
| 458,584 25,429,567 |
1,338,487 6,362 |
(3,316,580) 3,466,580 |
(1,519,509) 28,902,509 |
|||
| 1,344,849 | 150,000 | 27,383,000 |
66
67
The best of life, at the end of life, for everyone
@NLondonHospice northlondonhospice @NorthLondonHospice North London Hospice
North London Hospice 47 Woodside Avenue, London, N12 8TT Phone: 0800 368 7848 (Freephone) Email: nlh@northlondonhospice.co.uk
www.northlondonhospice.org
Charity No. 285300. Registered Address - 47 Woodside Avenue, London, N12 8TT. Company Reg No: 01654807 (England and Wales)